250 related articles for article (PubMed ID: 24442663)
21. Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
Auvray M; Elaidi R; Ozguroglu M; Guven S; Gauthier H; Culine S; Caty A; Dujardin C; Auclin E; Thibaut C; Combe P; Tartour E; Oudard S
Clin Genitourin Cancer; 2017 Jun; 15(3):e469-e476. PubMed ID: 27964892
[TBL] [Abstract][Full Text] [Related]
22. The relationship between platelet-lymphocyte ratio, neutrophil-lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 Fluorourasil Regimen: A single institute experience.
Dogan M; Eren T; Ozdemir N; Cigirgan CL; Zengin N
Saudi J Gastroenterol; 2015; 21(5):320-4. PubMed ID: 26458860
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
[TBL] [Abstract][Full Text] [Related]
25. Pre-treatment Peripheral Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Gastric Cancer.
Magdy M; Hussein T; Ezzat A; Gaballah A
J Gastrointest Cancer; 2019 Dec; 50(4):763-768. PubMed ID: 30058031
[TBL] [Abstract][Full Text] [Related]
26. Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
Murakami Y; Saito H; Shimizu S; Kono Y; Shishido Y; Miyatani K; Matsunaga T; Fukumoto Y; Fujiwara Y
Anticancer Res; 2019 May; 39(5):2583-2589. PubMed ID: 31092456
[TBL] [Abstract][Full Text] [Related]
27. The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer.
Hannarici Z; Yılmaz A; Buyukbayram ME; Turhan A; Çağlar AA; Bilici M; Tekin SB
Future Oncol; 2023 Feb; 19(4):315-325. PubMed ID: 37125596
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of Baseline Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Local and Advanced Gastric Cancer Patients.
Aldemir MN; Turkeli M; Simsek M; Yildirim N; Bilen Y; Yetimoglu H; Bilici M; Tekin SB
Asian Pac J Cancer Prev; 2015; 16(14):5933-7. PubMed ID: 26320475
[TBL] [Abstract][Full Text] [Related]
29. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
Hirahara T; Arigami T; Yanagita S; Matsushita D; Uchikado Y; Kita Y; Mori S; Sasaki K; Omoto I; Kurahara H; Maemura K; Okubo K; Uenosono Y; Ishigami S; Natsugoe S
BMC Cancer; 2019 Jul; 19(1):672. PubMed ID: 31286873
[TBL] [Abstract][Full Text] [Related]
30. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Are Respectively Associated with Prognosis of Gastric Cancer with Liver Metatasis Undergoing and without Hepatectomy.
Gao J; Wang Y; Li F; Zhu Z; Han B; Wang R; Xie R; Xue Y
Biomed Res Int; 2019; 2019():4213623. PubMed ID: 31687389
[No Abstract] [Full Text] [Related]
32. Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.
Cho KM; Park H; Oh DY; Kim TY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Oncotarget; 2017 Jan; 8(2):2329-2341. PubMed ID: 27911876
[TBL] [Abstract][Full Text] [Related]
33. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma.
Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K
Oncology; 2019; 97(1):7-17. PubMed ID: 31048577
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study.
Chen Y; Chen K; Xiao X; Nie Y; Qu S; Gong C; Su F; Song E
BMC Cancer; 2016 May; 16():320. PubMed ID: 27198767
[TBL] [Abstract][Full Text] [Related]
35. Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer.
Inoue D; Sekiguchi S; Yamagata W; Maeda G; Yamada D; Fujiwara S; Itou S; Kurihara M; Hijioka Y; Shimoji K; Fujiki J; Nakazono A; Horike H; Yoshioka A; Ogura Y; Hatao F; Imamura K; Namiki S
Oncology; 2019; 96(3):140-146. PubMed ID: 30368510
[TBL] [Abstract][Full Text] [Related]
36. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
38. Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.
Ock CY; Nam AR; Lee J; Bang JH; Lee KH; Han SW; Kim TY; Im SA; Kim TY; Bang YJ; Oh DY
Gastric Cancer; 2017 Mar; 20(2):254-262. PubMed ID: 27147244
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of preoperative neutrophils to lymphocytes ratio in patients resected for gastric cancer.
Graziosi L; Marino E; De Angelis V; Rebonato A; Cavazzoni E; Donini A
Am J Surg; 2015 Feb; 209(2):333-7. PubMed ID: 25190544
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients.
Xue P; Kanai M; Mori Y; Nishimura T; Uza N; Kodama Y; Kawaguchi Y; Takaori K; Matsumoto S; Uemoto S; Chiba T
Cancer Med; 2014 Apr; 3(2):406-15. PubMed ID: 24519894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]